Current evidence suggests that the inflammatory pathway in atherosclerosis culminates in altered concentrations of various markers in peripheral blood (31, 32) including CRP (44), IL-6, TNF-α, MCP-1, and ICAM1 (45–47). The gene discussed is CRP; the disease is atherosclerosis.